1) FOULDS, G.; R. M. SHEPARD & R. B. JOHNSON: The pharmacokinetics of azithromycin in human serum and tissues. J. Antimicrob. Chemother. 25 (Suppl. A): 73-82, 1990
2) BALDWIN, D. R.; R. WISE, J. M. ANDREWS, J. P. ASHBY & D. HONEYBOURNE: Azithromycin concentrations at the sites of pulmonary infection. Eur. Respir. J. 3: 886-890, 1990
3) RETSEMA, J.; A. GIRARD, W. SCHELKLY, M. MANOUSOS, M. ANDERSON, G. BRIGHT, R. BOROVOY, L. BRENNAN & R. MASON: Spectrum and mode of action of azithromycin (CP 62,993), a new 15-memberedring macrolide with improved potency against Gram-negative organisms. Antimicrob. Agents Chemother. 31: 1939-1947, 1987
4) HARDY, D. J.; D. M. HENSEY, J. M. BEYER, C. VOJTKO, E. J. MCDONALD & P. B. FERNANDES: Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides. Antimicrob. Agents Chemother. 32: 1710-1719, 1988
5) RYLANDER, M. & H. O. HALLANDER: In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP-62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum. Scand. J. Infect. Dis. Suppl. 53: 12-17, 1988